
Mark B Yagan MD
Interstitial Lung Diseases, Pulmonary Vascular Medicine
Physician
Join to view full profile
4321 Washington StSuite 6000Kansas City, MO 64111
Phone+1 816-756-2255
Fax+1 816-931-4080
Dr. Yagan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Yagan is a pulmonologist based in Kansas City, MO, specializing in interstitial lung diseases and pulmonary vascular medicine. He completed his medical education and training, including a fellowship in Pulmonary Disease and Critical Care Medicine, at the University of Missouri-Kansas City School of Medicine. His expertise includes pulmonary hypertension and interstitial lung disease. Dr. Yagan has contributed to research, with publications on topics such as lung responses to surgery, sedation in mechanical ventilation, and hospital-acquired pneumonia. Furthermore, he has participated in clinical trials related to pulmonary arterial hypertension and idiopathic pulmonary fibrosis. He holds several certifications from CMS for Meaningful Use Stages 1 and 2 across various electronic health record systems.
Education & Training
University of Missouri-Kansas City School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1989 - 1993
University of Missouri Kansas City School of MedicineClass of 1989
Certifications & Licensure
MO State Medical License 1991 - 2027
KS State Medical License 1995 - 2026
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification RelayClinical™ Solutions, McKesson, 2012, 2014-2017
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 4 citationsMetabolic and biochemical responses of the healthy human lung to nonthoracic surgery.Betty Herndon, Mark Yagan, George Reisz, J. C. Ireland
Lung. 2008-01-01 - 20 citationsSedation of the mechanically ventilated patient.Mark B. Yagan, Debbie White, Janet Staab
Critical Care Nursing Quarterly. 2000-02-01 - 2 citationsHospital-acquired pneumonia and its management.Mark B. Yagan
Critical Care Nursing Quarterly. 1997-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









